Efficacy of the salmeterol/fluticasone propionate dry powder combination product in the Diskus®:: A stratified study in patients on salmeterol alone or inhaled corticosteroids.

被引：0
|
作者：
Wolfe, J
Bell, T
Raphael, G
Weinstein, S
Baitinger, L
Woodring, A
Prillaman, B
House, K
Shah, T
机构：
[1] Allergy & Asthma Assoc Santa Clara Valley, San Jose, CA USA
[2] Ctr Asthma & Allergy, Missoula, MT USA
[3] Allergy & Asthma Specialists Med Grp, Huntington Beach, CA USA
[4] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
[5] Adult & Pediat Allergy & Immunol, Bethesda, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
879
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [21] Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals
    Murnane, Darragh
    Martin, Gary P.
    Marriott, Christopher
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (02) : 503 - 515
  • [22] Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone
    Katial, Rohit K.
    Bernstein, David
    Prazma, Charlene M.
    Lincourt, William R.
    Stempel, David A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (02) : 127 - 136
  • [23] Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma
    Nie, Hanxiang
    Zhang, Guqin
    Liu, Min
    Ding, Xuhong
    Huang, Yi
    Hu, Suping
    RESPIRATORY MEDICINE, 2013, 107 (03) : 347 - 354
  • [24] A Dose-Response Study to Examine the Methodology for Demonstrating the Local Therapeutic Equivalence of the Fluticasone Propionate Component of an Orally Inhaled Combination Therapy of Fluticasone Propionate/Salmeterol Dry Powder
    Allan, Richard
    Haughie, Scott
    Kerwin, Edward
    Ward, Jon
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (06) : 364 - 373
  • [25] Pharmacokinetic Bioequivalence of Two Fluticasone Propionate/Salmeterol Dry Powder Inhalers, OT329 Solis, and Advair Diskus
    Getz, Elise Burmeister
    Carroll, Kevin
    CHEST, 2017, 152 (04) : 768A - 768A
  • [26] Perception of diskus inhaler for administration of fluticasone propionate and salmeterol: A multicentre study in 703 patients.
    Brambilla, C
    Evano, I
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A630 - A630
  • [27] Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies
    Willem R. Pieters
    Bo Lundbäck
    Gunnar Johansson
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    Robert M.A. Thwaites
    Songkai Yan
    PharmacoEconomics, 1999, 16 : 9 - 14
  • [28] Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma
    Miller, David S.
    Yiu, Gloria
    Hellriegel, Edward T.
    Steinfeld, Jonathan
    ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (04) : 291 - 301
  • [29] Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II:: Study methodologies
    Pieters, WR
    Lundbäck, B
    Johansson, G
    Palmqvist, M
    Price, MJ
    Sondhi, S
    Thwaites, RMA
    Yan, SK
    PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 9 - 14
  • [30] Comparative efficacy of daily inhaled fluticasone propionate and episodic inhaled combined salmeterol/fluticasone propionate in children with recurrent wheezing
    Chamnanrua, Jiratchaya
    Daengsuwan, Tassalapa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB207 - AB207
12345